Published on GHDx (https://ghdx.healthdata.org)

Case-control study of effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease (IPD) in the U.S.: preliminary estimates

General Info

Geography 
United States of America (USA)
Coverage type 
Country
Time period covered 
January, 2010 - December, 2013
Data type
Epi surveillance
Keywords 
Pneumococcal pneumonia

Citation

Authors 
Moore M, Link-Gelles R, Guevara R, Rosen J, Barnes M, Petit S, Holtzman C, Lynfield R, Schaffner W, Harrison L, Currenti S, Dimond M, Reingold A, Farley MM, Harb S, Scherzinger K, Thomas A, McGee L, Beall B, Whitney C
Publication year 
2014
Suggested citation 

Moore M, Link-Gelles R, Guevara R, Rosen J, Barnes M, Petit S, Holtzman C, Lynfield R, Schaffner W, Harrison L, Currenti S, Dimond M, Reingold A, Farley MM, Harb S, Scherzinger K, Thomas A, McGee L, Beall B, Whitney C. Case-control study of effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease (IPD) in the U.S.: preliminary estimates. Presented at: 9th International Symposium on Pneumococci and Pneumococcal Diseases; 2014 Mar 9-13; Hyderabad, India. Poster. ISPPD-0329.

Source URL:https://ghdx.healthdata.org/record/case-control-study-effectiveness-13-valent-pneumococcal-conjugate-vaccine-pcv13-against